Larger studies in broader populations of people will tell us more about whether GLP-1 agonists will work for addiction, and if so, for whom
Most are mild-to-moderate and resolve over the titration period (820 weeks)
While semaglutide can be a powerful tool in your weight loss journey, we believe that long-term success is best achieved through sustainable lifestyle changes
Ozempic, Victoza, Rybelsus, and Mounjaro are approved for diabetes, not specifically for weight loss
Honda, Y., Kessoku, T., Sumida, Y., Kobayashi, T., Kato, T., Ogawa, Y., Tomeno, W., Imajo, K., Fujita, K., Yoneda, M., Kataoka, K., Taguri, M., Yamanaka, T., Seko, Y., Tanaka, S., Saito, S., Ono, M., Oeda, S., Eguchi, Y.,
Like GLP-1, GIP is involved in metabolic signaling